2012
Paracentesis
De Gottardi A, Yeo C, Garcia‐Tsao G. Paracentesis. 2012, 1158-1162. DOI: 10.1002/9781118321386.ch154.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsDiagnostic paracentesisTherapeutic paracentesisAscitic fluidNew-onset ascitesAdministration of albuminSpontaneous bacterial peritonitisSite of paracentesisFormal contraindicationBowel perforationAbdominal ultrasoundBacterial peritonitisMajor complicationsSpecific etiologyAbdominal cavityParacentesisAscitesCell countBlood culture bottlesPatient consentSingle procedureFrequent technical problemsLeakage of fluidTherapeutic purposesPatientsMedical procedures
1995
A randomized, double-blind, placebo-controlled trial of ursodeoxycholic acid in primary biliary cirrhosis
Combes B, Carithers R, Maddrey W, Lin D, Mcdonald M, Wheeler D, Eigenbrodt E, Muñoz S, Rubin R, Garcia-tsao G, Bonner G, West A, Boyer J, Luketic V, Shiffman M, Mills A, Peters M, White H, Zetterman R, Rossi S, Hofmann A, Markin R. A randomized, double-blind, placebo-controlled trial of ursodeoxycholic acid in primary biliary cirrhosis. Hepatology 1995, 22: 759-766. DOI: 10.1016/0270-9139(95)90294-5.Peer-Reviewed Original ResearchPrimary biliary cirrhosisSerum bilirubinBiliary cirrhosisMajor complicationsStratum 1Liver diseaseTreatment failureAdvanced primary biliary cirrhosisPlacebo-treated patientsPlacebo-controlled trialBile acid poolStratum 3Advanced diseaseLiver histologyPrognostic factorsMilder diseaseSingle doseUrsodeoxycholic acidUrsodiolSevere symptomsPatientsPlaceboLaboratory testsComplicationsBilirubin